Inventor · disambiguated record
James Matthaei
Also filed as: MATTHAEI JAMES · MATTHAEI JAMES F
7 granted patents·11 pending applications·22 citations·filing 2018–2025
81Inventor score
Files withSONOMA BIOTHERAPEUTICS INC4ENDOCYTE INC3SEATTLE CHILDRENS HOSPITAL3SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST3PURDUE RESEARCH FOUNDATION2
Top patents by PatentIndex Score
18 records- 0195US12269862B2Methods of use for CAR T cellsPURDUE RESEARCH FOUNDATION·Filed 2023·Granted Apr 8, 2025·2 cites·15 claims
- 0295US11311576B2Methods of use for CAR T cellsSEATTLE CHILDRENS HOSPITAL·Filed 2019·Granted Apr 26, 2022·10 cites·23 claims
- 0393US11779602B2Methods of use for CAR T cellsENDOCYTE INC·Filed 2019·Granted Oct 10, 2023·7 cites·44 claims
- 0486US11649288B2Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agentsSEATTLE CHILDRENS HOSPITAL·Filed 2018·Granted May 16, 2023·2 cites·20 claims
- 0577US12240870B2Sequencing method for CAR T cell therapyPURDUE RESEARCH FOUNDATION·Filed 2019·Granted Mar 4, 2025·1 cites·14 claims
- 0677US2025368718A1Methods of use for car t cellsENDOCYTE INC·Filed 2025·Application pending·0 cites
- 0776US2022257652A1Methods of use for car t cellsSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2022·Application pending·0 cites
- 0871US2025230216A1Sequencing method for car t cell therapyENDOCYTE INC·Filed 2024·Application pending·0 cites
- 0970US2023322925A1Phospholipid ether (ple) car t cell tumor targeting (ctct) agentsSEATTLE CHILDREN’S HOSPITAL DBA SEATTLE CHILDREN’S RES INSTITUTE·Filed 2023·Application pending·0 cites
- 1058US11753457B2Synovial extracellular matrix-specific chimeric antigen receptor for targeting regulatory T cells to treat autoimmune diseasesSONOMA BIOTHERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·0 cites·30 claims
- 1158US2025333697A1Tethered interleukin-2 recombinant receptors and methods of useSONOMA BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1257US12312416B2Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumorsSEATTLE CHILDRENS HOSPITAL·Filed 2019·Granted May 27, 2025·0 cites·18 claims
- 1355US2024010703A1Synovial extracellular matrix-specific chimeric antigen receptor for targeting regulatory t cells to treat autoimmune diseasesSONOMA BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1450US2023172981A1Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cellsSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2021·Application pending·0 cites
- 1549US2022125841A1Sodium fluorescein as a reversal agent for an anti-fluorescein car t cells and fluorescein-phospholipid-ethers or profluorescein-phospholipid-ethersSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENA RES INSTITUTE·Filed 2020·Application pending·0 cites
- 1649US2021317407A1Methods and compositions for stimulation of chimeric antigen receptor t cells with hapten labelled cellsSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2019·Application pending·0 cites
- 1745US2024417443A1Il5ra cell surface markersSONOMA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1843US2020405881A1Cell based methods and compositions for therapeutic agent delivery and treatments using sameUNIV WASHINGTON·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Matthaei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →